INTRODUCTION
The precise gonadotropin requirements of the developing ovarian follicle have not yet been established, and the contribution of luteinizing hormone (LH) in this process has been controversial (1) . While only basal levels of LH are required to support follicular steroid biosynthesis during the follicular phase, high tonic levels of LH negatively affect fertility (2-6). The exact mechanism by which increased levels of LH reduce fertility remains unsolved, but it is generally believed that LH induces a premature resumption of meiosis, leading to ovulation/retrieval of postmature oocytes or "aged" oocytes. Such oocytes have a reduced capacity to fertilize and to undergo normal embryo development (review in Ref. 7) . Increased LH levels may also induce an abnormally high androgen production by theca cells. This may subsequently reduce the implantation potential of the possible preembryos in that cycle (7) (8) (9) .
During the past decade, a number of different ovarian stimulation regimens have been used to improve the development and maturation of follicles. In the 1980s the majority of stimulation regimens did not include pituitary downregulation. This changed during the 1990s and today pituitary downregulation is effected before ovarian stimulation is commenced in the majority of IVF cycles. Consequently, the circulating levels of LH during ovarian stimulation have effectively been reduced (2, 3, 10) , generally to levels even lower than those observed during the natural menstrual cycle.
However, in contrast to the predicted negative effect of LH, in vitro fertilization and cleavage rates of oocytes have remained remarkably constant, around 55 to 65%, independent of whether pituitary downregulation is used during ovarian stimulation or whether the circulating level of LH is not reduced. Furthermore, one recent study showed that fertilization, cleavage, and conception rates are unaffected by the use of exogenous gonadotropins containing LH (i.e., Pergonal; Serono) compared to the use of preparations with negligible LH activity [i.e., urinary derived follicle stimulating hormone (FSH)-HP] (10).
In contrast to LH, circulating levels of FSH during ovarian stimulation differ significantly from that observed during the natural menstrual cycle. Naturally FSH rises in the early follicular phase, after which a nadir is reached shortly before the midcycle surge of gonadotropins. During ovarian stimulation FSH levels exceed those of the natural menstrual cycle several times. After approximately 5 days of stimulation FSH levels reach a constant high plateau, which is maintained until the time of ovulation induction (10) (11) (12) .
High circulating levels of FSH have not previously been ascribed adverse effects. But recently it has been suggested that such high FSH levels may be involved in premature luteinization (13) . FSH may also promote a high local synthesis of androgens through paracrine stimulation of peptide growth factors produced by granulosa cells (14) .
The aim of the present retrospective study was to evaluate the effects of the high circulating levels of FSH during administration of exogenous gonadotropins on subsequent preembryo development and pregnancy potential. In normogonadotropic pituitary downregulated women undergoing IVF treatment, serum levels of FSH and LH were correlated with in vitro fertilization and cleavage of retrieved oocytes.
MATERIALS AND METHODS

Patients and Hormonal Treatment
A total of 244 women undergoing IVF treatment at the fertility clinic of Odense University Hospital was included in this study. The standard hormonal treatment consisted of the following elements: (i) Downregulation was induced with gonadotropin-releasing hormone agonist (GnRHa) (Suprefact, Hoechst, Copenhagen Denmark), 0.5 mg s.c. daily for a minimum of 14 days, starting in the midluteal phase of the cycle. When downregulation was confirmed by a serum estradiol concentration of less than 100 pM and a quiescent ovary as judged by ultrasound, the dose of GnRHa was reduced to 0.2 mg s.c. daily until the day of human chorionic gonadotropin (hCG) injection, (ii) Ovarian stimulation was achieved with a fixed dose of gonadotropin of 225 IU per day for 7 days (see below). On day 8 of stimulation the ovarian response was monitored by ultrasound and serum estradiol measurements and the daily dosage of exogenous gonadotropin was individualized accordingly. When at least four follicles with a diameter (i.e., mean of two measurements) exceeding 17 mm were observed, an ovulatory dose of 10,000 IU hCG (Profasi; Serono Nordic Solne Sweden) was given by i.m. injection.
Cleavage rate and preembryo development were defined as the proportion of oocytes which fertilized and cleaved into at least a two-cell pre-embryo. Details on oocyte retrieval, in vitro culture, preembryo transfer, and luteal support have been described elsewhere (10) .
The inclusion criteria were: (i) female age younger than 40 years; (ii) a normal menstrual cycle ranging from 26 to 32 days; (iii) normal pretreatment serum concentrations of FSH and LH (i.e. less than 10 IU/ L) on cycle day 2 obtained less than 6 months before the start of treatment; and (iv) a standard ovarian stimulation regimen planned and used. The exclusion criteria were: (i) infertility caused by an endocrine abnormality such as polycystic ovary syndrome and absence of ovarian function and (ii) cases in which intracytoplasmatic sperm injection or donor semen was used.
According to the type of gonadotropin administered the women were allocated to one of three groups: (i) the FSH-HP group, consisting of 82 women who were treated with urine-derived, highly purified FSH (Fertinorm HP, Serono Nordic); (ii) the hMG group, consisting of 93 women treated with human menopausal gonadotropin (Pergonal; Serono Nordic); and (iii) the rec-FSH group, consisting of 69 women treated with human, recombinant FSH (Gonal F; Serono Nordic).
The women in the hMG and FSH-HP groups were part of a prospective randomized study running from October 1994 to April 1995, and the results of this study have been published (10) . A total of 175 women from this former study, namely, all those for whom all blood samples were taken and all data present, was included in the present study. The 69 women in the rec-FSH group were treated consecutively during the period December 1995 to January 1996. During the 16-month period of the present study there were no changes in treatment policy or in laboratory procedures.
The study was approved by the Ethical Committee of the counties of Fyn and Vejle.
Blood Sampling
In all patients blood was sampled three times during treatment: i) on the day on which pituitary downregulation was confirmed and ovarian stimulation initiated and before the first injection of exogenous gonadotropin was given (i.e., stimulation day 1); ii) on stimulation day 8 before the injection was given and 18 hr after the last injection of exogenous gonadotropin; and iii) on the day of oocyte retrieval, i.e., 36 hr after the injection of hCG and approximately 72 hr after the last injection of exogenous gonadotropin. The sera were immediately analyzed for estradiol and aliquots frozen at -20°C for later analysis of FSH and LH.
Hormone Assays
Estradiol was measured by fluoroimmunoassay (AutoDELPHIA oestradiol kit; Wallac Denmark A/S, Allerod, Denmark). Concentrations of FSH and LH were measured using an automated fluoroimmunoassay system (AutoDELPHIA hFSH and hLH sp kits; Wallac). The intra-and interassay coefficients of variation were 4.2 and 3.6% for estradiol, 2.3 and 4.5% for FSH, and 1.9 and 3.8% for LH, respectively.
Statistical Methods
Results are expressed as the mean ± SE unless otherwise stated. Differences between two groups were tested using Student's t test and chi-square test. Correlation between variables was established using regression analysis.
RESULTS
The study comprised a total of 244 women, who underwent one treatment cycle each. Characteristics of ovarian stimulation and IVF outcome are given in Table I . Women receiving different gonadotropin preparations were comparable with regard to all parameters except for the number of retrieved oocytes in the group receiving HMG, which was significantly higher than in the group receiving rec-FSH. The frequency with which pregnancy was achieved was also similar in the three groups.
Concentrations of FSH and LH on the day ovarian stimulation was initiated (i.e., day 1), on day 8 of ovarian stimulation, and on the day of oocyte retrieval are shown in Table II . After 7 days of stimulation, during which all women received 225 IU FSH/day, concentrations of FSH rose to an overall average of 11.5 IU/L. There was a significant difference between the three groups, the level being highest in the urinary FSH-HP group and lowest in the rec-FSH group. Table III shows the correlation between the measured FSH concentrations and the mean frequency at which the retrieved oocytes subsequently fertilize and cleave in vitro and the number of obtained pregnancies. On day 1, when pituitary downregulation is achieved and before ovarian stimulation with exogenous gonadotropins is initiated, there is no significant correlation between levels of FSH and subsequent formation of preembryos. On day 8 of ovarian stimulation there is a significant negative correlation between FSH levels and the subsequent frequency at which preembryos form; concentrations in the interval of 4-7 IU FSH/L result in the formation of preembryos in 64% of the retrieved oocytes, which gradually declines to only 30% in those women who have an FSH level above 20 IU FSH/L (r = 0.36, P < 0.0001). On the day of oocyte retrieval a similar correlation is observed (r = 0.42, P < 0.0001). Each of the three gonadotropin preparations separately shows a picture similar to all measurements taken together (data not shown). The actual numbers of preembryos developed in vitro show a similar inverse significant correlation of the levels of FSH on day 8 (r = 0.18, P < 0.01) and on the day of oocyte retrieval (r = 0.27, P < 0.0001). No pregnancies are observed in the group of women with the highest levels of FSH on day 8. Table IV shows the correlation between the circulating concentrations of LH and the mean frequency at which the retrieved oocytes subsequent fertilize and cleave in vitro and the number of pregnancies achieved. On day 1 a significantly higher cleavage rate 10, 1997 is found in the group of women with LH levels between samples showed a higher LH concentration than the 0 and 1 IU/L compared to those with LH levels in the mean pretreatment value of 5.8 IU LH/L (5 samples range of 4-7 IU/L, reflecting a significant correlation on day 1, 1 sample on day 8, and none on the day of between LH day 1 levels and the cleavage rate (r = aspiration). Pregnancy was achieved in two of these 0.24, P < 0.001) and the number of preembryos (r = six cycles. 0.24, P < 0.001). On day 8 a significantly lower cleav-A high or a low FSH concentration during the course age rate is found in the group of women who have a of ovarian stimulation was not correlated with a con-LH level of more than 3 IU/L, representing, however, comitant high or low LH concentration, i.e., FSH levels only seven cycles. The level of LH during ovarian on day 8 did not correlate with LH levels on day 8 stimulation does not seem to correlate with the (P > 0.10), nor did FSH and LH levels on the day of achievement of pregnancy. Of the total 244 cycles, 6 oocyte retrieval correlate (P > 0.10). The mean concentrations of FSH and LH on each of the 3 monitored days were similar between those who did and those who did not become pregnant (data not shown).
The age of the woman showed no correlation with the oocyte cleavage rate or with the FSH level on day 1, day 8, and the day of oocyte retrieval (data not shown).
The derivation of patient variation in FSH levels under GnRHa suppression was not predicted by the FSH level on day 1; there was no significant correlation of the FSH levels on day 1 and on day 8 or on the day of oocyte retrieval (i.e., high levels of FSH on day 1 are not correlated with high levels on day 8 or on the day of oocyte retrieval; data not shown). Each of the three gonadotropin preparations showed a similar picture.
The body mass index (BMI) correlates inversely with the concentration of FSH on day 8 of ovarian stimulation for each of the three gonadotropin preparations separately and for all the measurements taken together. No such correlation was seen between BMI and the pretreatment values of FSH and LH (data not shown). The range of BMI was from 17 to 39 kg/m 2 . When the BMI was divided into four groups (i.e., 17-20, 21-24, 25-28, and 29 or more kg/m 2 ), there were no significant differences among the four groups with regard to the frequency at which the oocytes fertilized and cleaved in vitro.
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DISCUSSION
During the natural midcycle surge of gonadotropins the concentration of LH exceeds that of FSH. While concentrations of LH are in the range of 50-90 IU/L, the mean concentration of FSH reaches 9.3 IU/L (range, 3.9-13.3 IU/L) during the midcycle surge measured with the assay used in this study (kit instructions, AutoDELPHIA). The mean concentration of FSH in women undergoing ovarian stimulation on day 8 was 11.5 IU/L in this study and exceeded the expected midcycle surge of gonadotropins by almost 25%. Nearly 75% of all the measured FSH concentrations on day 8 were above the mean peak FSH level. Furthermore, in the original work by Ross et al. (15) the midcycle FSH peak is defined to "exceed the mean FSH value of the second half of the follicular phase be at least 40%." In the present study, the concentration of FSH on stimulation day 8 exceeded the mean FSH value of the second half of a normal follicular phase (approximately 4 IU/L) by more than 250%. Therefore, this study shows that levels of FSH during ovarian stimulation reach and exceed ovulatory heights of FSH. This observation was most clearly expressed in the group of women who received urinary FSH-HP, with the mean value on day 8 of stimulation being almost 50% higher and above the range of the normal midcycle FSH surge. Therefore, these data show that levels of FSH are truly supraphysiological and indicate that some of the physiological actions that FSH under-takes during the natural midcycle surge of gonadotrocapable of inducing resumption of meiosis in cultured pins may be expressed during ovarian stimulation with mouse oocytes, whereas recombinant LH and hCG at exogenous FSH preparations several days before ovuconcentrations up to 1500 IU/L are without any such lation is induced with hCG.
effect (19) . These studies are in agreement with earlier Pituitary downregulation was effected and the ovastudies which showed that cumulus cells possess recepries were quiescent in all women before ovarian stimutors for FSH but not for LH/hCG (20, 21) . lation was commenced, and levels of LH consequently Animal studies seem to support the idea that FSH remained at a very low level throughout the stimulation in vivo may facilitate a premature resumption of meioperiod in the majority of cycles. Concentrations of LH sis. A study (18) showed that subovulatory doses of showed no correlation with the frequency at which the pure FSH given to rats in proestrus were able to induce retrieved oocytes underwent preembryo development asynchrony in resumption of meiosis of folliclein vitro or with the achievement of conception. This enclosed oocytes in vivo and ovulation. The follicleindicates that concentrations of LH are too low to enclosed oocytes resume meiosis before the midcycle affect fertility negatively. In contrast, oocytes from surge of gonadotropins. When mated, these rats women with high concentrations of FSH showed a showed a pronounced reduction in fertility. poor cleavage rate and developed a reduced number Taken together and based on observations in animal of preembryos, whereas low concentrations of FSH studies, the present study may suggest that the FSH correlated with a subsequent high cleavage rate. Furlevels observed during ovarian stimulation reach a thermore, clinical pregnancies were not observed in magnitude that is sufficient to induce resumption of the group of women with high FSH levels. Quite unexmeiosis in the follicle-enclosed oocyte without trigpectedly, therefore, this study suggests that FSH levels gering the actual ovulatory signal. This hypothesis during the follicular phase exceeding ovulatory heights parallels the suggested detrimental effect on fertility have negative effects on oocyte maturation and fertiliof elevated levels of LH during the follicular phase. zability. This study does not reveal the cause of this The present observations indicate that future ovarian correlation. However, several lines of evidence seem stimulation regimens may profit from mimicking the to suggest that the two key events in the ovulatory natural follicular phase more closely. After an initial process, the resumption of meiosis in the follicle recruitment phase in which the FSH levels are raised enclosed oocyte and the actual ovulatory process itself, above the threshold and follicles are stimulated to resulting in expulsion of the oocyte from the follicle grow, FSH concentrations should not continue to rise to the oviduct, exhibit different sensitivities to the but should be kept at a lower level, possibly around the gonadotropins. In vitro and in vivo studies in rats have threshold level. This could potentially lead to sufficient shown that resumption of meiosis is induced in oocytes follicular growth without inducing negative effects by of all preovulatory follicles by exposing the ovaries overexposure to gonadotropins. to only 5 to 30% of the preovulatory surge without
The present retrospective study does not provide eliciting the ovulatory process (16, 17) . Furthermore, sufficient information for a comparison of the clinical it is well known that the oocyte is fertilizable for only outcome among the three types of gonadotropin prepaa limited period after ovulation, maybe only around rations. Rather, we focused on the marked difference 12 hr. After this period, fertilization does not result in in the frequency at which the retrieved oocytes subsea viable conception. The decline in fertilizablity with quently cleave in vitro. This may be a result of the aging may be an intrinsic property of unfertilized absolute concentrations of FSH or, more likely, repreoocytes, and it has been suggested that this aging is sent differences in the biological activity of the FSH related to meiotic resumption (18) . It may therefore preparations possibly represented by the isohormone be speculated that the high FSH levels during ovarian profile (22, 23) . From the present study the inverse stimulation induce resumption of meiosis without relationship between the observed FSH concentrations inducing the ovulatory process itself, i.e., a premature on day 8, when the amount of administered exogenous resumption of meiosis, leading to ovulation/retrieval of FSH was identical in all three groups, and the cleavage "aged" oocytes with a reduced potential for preembryo rate may indicate that the biopotency of rec-FSH is development and conception.
higher than that of the other two types of gonadotropin There is actually also good evidence from in vitro preparations. The rec-FSH preparation also seems to studies to support a central role for FSH in regulating have a more basic FSH isohormone profile compared gonadotropin-induced resumption of meiosis in vivo.
to the other two FSH preparations (22, 23) . This is, Recent studies have shown that only 8 IU/L of FSH is however, flawed by the difficulty of measuring differ-ent FSH isoforms immunologically (24) , and further prospective studies are needed to clarify this issue. It will also be interesting to evaluate whether the different FSH isoforms affect resumption of meiosis differently. In this study the level of FSH during ovarian stimulation did not correlate with the age of the woman. Furthermore, there is no correlation with the FSH concentration on day 1, i.e., before ovarian stimulation is commenced. There was, however, an inverse correlation between FSH and BMI, expressed in each of the three groups receiving different gonadotropin preparations and in the all the samples taken together. A similar correlation has been found in women with a BMI above 25 kg/m2 (25) . Therefore, some of the great variability in FSH levels on day 8 may be explained by differences in BMI between the women. Because no significant correlation was found between the BMI and the cleavage rate of the retrieved oocytes, obesity of the women cannot explain the observed correlation between levels of FSH and the oocyte cleavage rate.
In conclusion, the present study suggests that elevated concentrations of FSH as a result of exogenous administration of gonadotropins negatively affect oocyte maturation and fertilizability. The mechanism behind this negative effect may be caused by a premature resumption of meiosis, leading to retrieval of "aged" or postmature oocytes.
